# Arcus Biosciences, Inc.: Form 8-K, filed Jun 28, 2023

- Company: [Arcus Biosciences, Inc.](/companies/rcus.md) (CIK 1724521)
- Form: 8-K
- Filed: 2023-06-28
- Accepted by EDGAR: Jun 28, 2023, 08:25 ET
- Period: 2023-06-27
- Accession: 0000950170-23-030273
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1724521/000095017023030273/rcus-20230627.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1724521/000095017023030273/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1724521/000095017023030273/rcus-20230627.htm

Filed Jun 28, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-030273. Last ingested by Listed: Nov 4, 2026, 17:06 ET. No prices; not investment advice.
